DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LY3185643
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3185643
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATOROLIMUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Blood group Rh(D) polypeptide other
ATOROLIMUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
SPIRADOLINE
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder
Unknown
SPIRADOLINE
×
Maximum Phase:
1
First Approval:
None
UNII:
N18ZH0M4NP
Molecule Type:
Small molecule
Molecular Formula:
C22H30Cl2N2O2
Molecular Weight:
425.4
AlogP:
4.56
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CVX-241
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
CVX-241
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CHLORCYCLIZINE
1
Small molecule
Investigational
Unknown
Unknown
Hypersensitivity
Unknown
CHLORCYCLIZINE
×
Maximum Phase:
1
First Approval:
None
UNII:
M26C4IP44P
Molecule Type:
Small molecule
Molecular Formula:
C18H21ClN2
Molecular Weight:
300.83
AlogP:
3.68
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PUQUITINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PUQUITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WFG29AB872
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
DV-281
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
DV-281
×
Maximum Phase:
1
First Approval:
None
UNII:
4LOR72V17G
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FF-10101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
FF-10101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H38N8O2
Molecular Weight:
530.68
AlogP:
3.13
PSA:
126.28
HBD:
3.0
HBA:
#RotB:
13.0
Source:
MGS-0210
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MGS-0210
×
Maximum Phase:
1
First Approval:
None
UNII:
12XH8EKL2A
Molecule Type:
Small molecule
Molecular Formula:
C22H28Cl2FNO5
Molecular Weight:
476.37
AlogP:
4.53
PSA:
98.85
HBD:
2.0
HBA:
#RotB:
11.0
Source:
FACTOR IX COMPLEX
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FACTOR IX COMPLEX
×
Maximum Phase:
1
First Approval:
None
UNII:
FW411QXD5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELUFORSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
ELUFORSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
V30WFP6S2Y
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CANOCTAKIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
CANOCTAKIN
×
Maximum Phase:
1
First Approval:
None
UNII:
MU4128F2CO
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PWT-33579
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase p110-alpha subunit inhibitor
PWT-33579
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIATERMIN
1
Protein
Investigational
Unknown
Unknown
Parkinson Disease
GDNF family receptor alpha-1 agonist
LIATERMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
PI2EOQ4KE3
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PSI-697
1
Small molecule
Investigational
Unknown
Unknown
Scleritis
Unknown
PSI-697
×
Maximum Phase:
1
First Approval:
None
UNII:
LH1XC916ME
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClNO3
Molecular Weight:
367.83
AlogP:
4.76
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRX-518
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant
Tumor necrosis factor receptor superfamily member 18 agonist
TRX-518
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MITOQUINOL CATION
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MITOQUINOL CATION
×
Maximum Phase:
1
First Approval:
None
UNII:
65M41NIO61
Molecule Type:
Small molecule
Molecular Formula:
C37H46O4P+
Molecular Weight:
585.75
AlogP:
8.08
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
16.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
AVOPLACEL
1
Cell
Investigational
Unknown
Unknown
Unknown
Unknown
AVOPLACEL
×
Maximum Phase:
1
First Approval:
None
UNII:
79NT7I8J0C
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHANESULFONYL FLUORIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHANESULFONYL FLUORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
9H250YYY0R
Molecule Type:
Small molecule
Molecular Formula:
CH3FO2S
Molecular Weight:
98.1
AlogP:
-0.08
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
96
97
98
99
100
101
102
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA